CXCL11, referred to as interferon-inducible T-cell alpha chemoattractant (I-TAC), could drive Th1 cells to secrete proinflammatory cytokine IL-6 in the inflammatory bowel disease (Liu et al., 2011). Here, IL6 is linked to inflammatory bowel disease.